Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
2019-2023 Europe HIV/AIDS Diagnostics Market: France, Germany, Italy, Spain, UK - Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers
... the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV - 1/2/Combo , HIVAg/HIV NAT , HTLV-I/II, Western Blot and other ... Read More
-
2019-2023 Europe Sexually-Transmitted Diseases (STD) Diagnostics Market: France, Germany, Italy, Spain, UK - Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers
... provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market ... Read More
-
Thailand Pharmaceuticals & Healthcare Q1 2019
... financial challenges facing the country'suniversal healthcare. Nevertheless, Thailand's long-term story is more positive, and the country will benefit from a number of keypharmaceutical market drivers such as an ageing population and a greater burden of ... Read More
-
Philippines Pharmaceuticals & Healthcare Q1 2019
... plans to improve access to health services and a growing prevalence of non-communicable diseases among thepopulation. However, the government’s implementation of cost-containment measures and the growing use of generic medicineswill limit opportunities for innovative drugmakers. Read More
-
United States Pharmaceuticals & Healthcare Q1 2019
... companies, which have been under pressure from PresidentTrump to lower costs for patients. Nevertheless, due to widespread concern among politicians and the public, high drug prices willbe the major issue in the US pharmaceutical market ... Read More
-
Ghana Pharmaceuticals & Healthcare Q1 2019
... has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a ... Read More
-
Marijuana Stores
... The multibillion-dollar global industry is experiencing strong growth, though the newness of the market and variance in regulation across geographies creates major barriers to entry. The industry includes medical marijuana dispensaries and stores that sell ... Read More
-
Biotechnology Product Manufacturing
... Switzerland-based Roche), Gilead Sciences, and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech firms ... Read More
-
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
... well as meet the growing pressure to control costs from consumers, insurance companies and governments has led many biopharmaceutical manufacturers to resort to innovative methods of production. Implementation of process intensification (continuous manufacturing) and use ... Read More
-
Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More
-
Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More
-
2019-2023 Germany Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and ... Read More
-
2019-2023 UK Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market ... Read More
-
NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
2019-2023 France Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and ... Read More
-
2019-2023 Italy Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and ... Read More
-
2019-2023 US Sexually-Transmitted Diseases (STD): Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
... forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs. In addition ... Read More
-
Lithuania Pharmaceuticals & Healthcare Q1 2019
... of quarterly price revisions for reimbursed medicines, the lowering ofvalue-added tax on non-reimbursed prescription medicines and the introduction of a maximum mark-up for reimbursed medicines.The changes mainly facilitate access to medicines, thus boosting volumes, but ... Read More
-
Mozambique Pharmaceuticals & Healthcare Q1 2019
... to deter any meaningful investmentfrom multinational drugmakers. Although growth will remain positive over our forecast (in local currency terms), the market willremain one of the least attractive in Sub-Saharan Africa, weighed down further by extremely ... Read More
-
Spain Pharmaceuticals & Healthcare Q1 2019
... of the generic drug sector and the government’s continuedfocus on cost-containment measures targeting prescription drug expenditure. These trends, along with a subdued economicoutlook, make Spain one of the more challenging markets in Western Europe for ... Read More
-
Chile Pharmaceuticals & Healthcare Q1 2019
... interest to innovative drugmakers, not least due to the deep-rootedpreference for patented drugs and the business-friendly operating environment. However, the threat of compulsory licenses and aweak regulatory environment will continue to present challenges for drugmakers. Read More
-
Estonia Pharmaceuticals & Healthcare Q1 2019
... growth in the market will be boosted by an increase in healthcare funding as well as thegovernment’s long-term health development plan. We have revised our short- and medium-term outlook for public healthcareexpenditure, boosting drugmaker opportunities. Read More
-
Norway Pharmaceuticals & Healthcare Q1 2019
... countries' pharmaceutical markets. In fact, Norway's stringent drugpricing policies will continue to limit drugmaker opportunities, despite sustained market growth. On the upside, an ageingpopulation and the rising demand for chronic disease treatment underpin market growth ... Read More
-
Tunisia Pharmaceuticals & Healthcare Q1 2019
... will challenge foreign investment into the sector.Highlighting the market's longer-term potential, some multinational drugmakers have shown their willingness to do business in thecountry, though the majority choose to operate indirectly to minimise the risks involved. Read More
